Skip to content

Marsh & Mclennan Companies

NYSE: MRSH · USD

Marsh & Mclennan Companies (MRSH) Economic Moat Analysis56

Competitive advantages, dated evidence and erosion risks.

Narrow economic moat

Marsh has a narrow moat from specialized expertise, proprietary tools and established insurance-market relationships. Higher new-business and renewal revenue in 2025, followed by underlying growth in 2026, supports current commercial relevance. Mobile talent, client insourcing and penalty-free consulting termination constrain durability. Marsh's realized pricing power remains unestablished: insurance premium movements are distinct from its own commission rates and fees. Profitable operations support resilience, but weaker cash generation, increased borrowing and litigation charges temper financial and management assessments.

Intangible assets

Specialized analytics, proprietary data and tools, and established reinsurance trading relationships support differentiated advice and placement capabilities. Higher new-business and renewal revenue provides operating corroboration, although the disclosures do not isolate the contribution of each capability.

Durability
A current, moderately durable advantage is supported by recurring capabilities and continuing underlying growth. The historical patented-platform disclosure adds context but does not establish current patent protection or exceptional durability.
Competitors
Comparison not established
Erosion risks
Expertise can move with employees; clients have historically substituted internal resources for consultants. Consulting engagements can be terminated without penalty. Generative AI entrants and disintermediation present potential erosion rather than demonstrated displacement.
What would invalidate the thesis
Sustained declines in renewal revenue and underlying demand accompanied by disclosed client migration, insourcing or substitution would undermine the advantage. Evidence that proprietary tools and market relationships no longer differentiate client outcomes would also invalidate the thesis.
Evidence (5) · Counterevidence (4)

Changes since the previous analysis

  • Retain the narrow verdict and the previously assessed numerical grades after re-examining the current catalog.
  • Explicitly retain realized_pricing as null: underlying growth and insurance premium movements do not isolate Marsh's own pricing outcomes.
  • Treat MarketConnect's patent disclosure as historical context, and integration completion as a management assertion rather than demonstrated acquisition returns.
  • Competitor coverage remains unestablished; companies listed for executive-compensation benchmarking are not treated as demonstrated business competitors.

Evidence limitations

  • Evidence consists of issuer filings and issuer results releases; differentiated capabilities are described by management and corroborated indirectly by operating demand, without comparative client-outcome evidence.
  • Competition passages identify generic categories. Named compensation-survey companies do not establish competitive coverage, so the competitors array is empty.
  • No isolated commission-rate or consulting-fee realization, quantified client retention, switching expenditure, current patent duration or demonstrated network effect is supplied.
  • Regulatory capital requirements, eligible capital, quantified undrawn facilities and a complete debt maturity schedule are absent. Financial-services grades are bounded qualitative corporate assessments, not regulatory-capital findings.
  • All financial-assessment citations come from sources filed in 2026, within 550 days of assessment. The February 2025 platform disclosure supports historical moat context only; supplied dates retain dateKind filed.
  • Ownership compliance, acquisition-level returns and repurchase valuation benefits are unestablished. Projected Thrive savings and prospective awards are not treated as realized achievements.

Financial indicators to test against the thesis

Calculated from annual filings. Missing data remains unavailable. Detailed financial charts remain in the other topics.

Financial indicators to test against the thesis
PeriodGross marginOperating marginROICFCF margin
2021—21.8%16.7%15.7%
2022—20.7%15.7%14.5%
2023—23.2%18.5%16.9%
2024—23.8%16.3%16.3%
2025—23.1%15.0%18.5%

Pricing power—

  • Pricing outcomes

    The passages disclose negotiated commissions and fees but do not isolate changes in Marsh's realized rates. Higher renewal revenue combines multiple drivers, and declining insurance premiums concern the underlying insurance market. Neither establishes Marsh's own price realization after volume and mix.

  • Customer demand

    Higher renewal revenue supports repeat demand indirectly, without identifying renewal counts, retention rates or price contributions. Clients can follow departing professionals, and consulting clients can terminate without penalty. Repeat business is demonstrated, while strong contractual stickiness is not.

  • Margin resilience

    Third-quarter adjusted operating margin held at 22.7%, while GAAP margin declined to 17.7% from 18.4%; nine-month operating income also fell. Adjusted margins exclude specified items and use adjusted revenue. Litigation, integration costs and changed adjustment methodology limit interpretation as evidence of pricing strength.

  • Pricing freedom

    Commission rates and fees depend on coverage, insurer selection and negotiations with clients. Policy audits can reduce commissions, while consulting engagements may end without penalty. These are disclosed constraints on economic terms; broad unilateral fee-setting or durable contractual price protection is unestablished.

Management63

  • Capital discipline

    Annual operating cash generation improved in 2025, and acquisitions contributed disclosed revenue. In nine-month 2026, cash generation weakened while dividends and repurchases exceeded operating cash after capital expenditure and borrowing increased. Spending outcomes are mixed; revenue contribution alone does not demonstrate acquisition returns.

  • Incentive alignment

    Actual multi-year vesting, forfeiture provisions and executive ownership requirements support alignment. A realized 0.88x relative-TSR modifier reduced the disclosed PSU payout to 176% of target, demonstrating operation of the mechanism. Ownership compliance and exceptional compensation effectiveness remain unestablished.

  • Execution

    Underlying revenue growth and improved 2025 operating cash generation support execution through indirect operating evidence. Management reports completed McGriff integration, but related costs continued in 2026, cash generation weakened and nine-month operating income declined. Integration completion does not establish realized acquisition returns.

  • Governance

    An otherwise independent board, separated CEO and chair roles, shareholder special-meeting rights and an adopted conduct clawback provide strong disclosed safeguards. The realized litigation charge warrants scrutiny but does not establish an adjudicated oversight failure. Exceptional effectiveness of these governance structures remains unproven.

Sources and methodology

Current publication · Updated 21/10/2026 · Version 11

AI interpretation based on checked source excerpts. Issuer assertions and evidence limitations remain explicit.

Policy quality-scores-3: six equally weighted categories. The overall score requires full coverage. Missing inputs are not zero. Qualitative grades are sourced interpretations, not probabilities. 5/6 · 29/10/2026

Moat56

Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.

structural advantage · 3/4 · Specialized reinsurance relationships, analytics and proprietary tools support differentiation. Higher new-business and renewal revenue provides operating corroboration, while the historical patented platform adds context. The evidence supports a narrow intangible advantage; comparative superiority, cost leadership and network effects remain unproven.

durability · 2/4 · Established market relationships and proprietary capabilities continue alongside underlying growth. However, professionals can take client relationships elsewhere, and clients have historically substituted internal resources. These constrain persistence; the passages establish neither contractual exclusivity nor exceptional protection against replication.

customer dependency · 2/4 · Higher renewal revenue and specialized reinsurance services indicate continuing usefulness indirectly. They do not establish hard dependency or a retention rate. Employee-related client mobility, historical insourcing and penalty-free consulting termination demonstrate limits to customer captivity.

erosion resilience · 2/4 · Renewal and new-business growth despite declining insurance premium rates, followed by 5% underlying growth in nine-month 2026 revenue, supports demand resilience. Operating income nevertheless declined year over year. AI competition is a disclosed threat, without evidence of realized displacement.

Pricing power—

Insufficient evidence for every rubric criterion; no category score is inferred.

realized pricing · — · The passages disclose negotiated commissions and fees but do not isolate changes in Marsh's realized rates. Higher renewal revenue combines multiple drivers, and declining insurance premiums concern the underlying insurance market. Neither establishes Marsh's own price realization after volume and mix.

retention · 2/4 · Higher renewal revenue supports repeat demand indirectly, without identifying renewal counts, retention rates or price contributions. Clients can follow departing professionals, and consulting clients can terminate without penalty. Repeat business is demonstrated, while strong contractual stickiness is not.

margin resilience · 2/4 · Third-quarter adjusted operating margin held at 22.7%, while GAAP margin declined to 17.7% from 18.4%; nine-month operating income also fell. Adjusted margins exclude specified items and use adjusted revenue. Litigation, integration costs and changed adjustment methodology limit interpretation as evidence of pricing strength.

contractual freedom · 1/4 · Commission rates and fees depend on coverage, insurer selection and negotiations with clients. Policy audits can reduce commissions, while consulting engagements may end without penalty. These are disclosed constraints on economic terms; broad unilateral fee-setting or durable contractual price protection is unestablished.

Predictability100

Financial-sector stability over 5 consecutive reported annual periods: equal weights for nondeclining revenue frequency, revenue-growth volatility (5–40pp), positive consolidated earnings frequency, and net-income/revenue margin volatility (3–20pp). Uses reported accounting scope; not industrial FCF or a growth forecast.

Nondeclining revenue years (%)
100.00
Revenue growth volatility (pp)
2.26
positiveEarningsShare
100.00
netMarginStdDev
0.70
observedAnnualPeriods
5.00

Financial strength50

Qualitative financial_services assessment: equal-weight average of four current evidence-backed grades (0–4), scaled to 100. Policy financial-services-1; not an industrial ratio score or credit rating.

capital adequacy · 2/4 · Positive consolidated equity and substantial earnings support a corporate buffer, alongside significant short- and long-term debt. Goodwill and intangible assets exceed accounting equity, limiting its interpretation as loss-absorbing capital. This is a mixed qualitative broker assessment; eligible regulatory capital and applicable headroom are unavailable.

liquidity funding · 2/4 · Positive operating cash generation and actual debt issuance and repayments demonstrate funding access. Corporate cash declined, some foreign cash is required for operations or collateral, and the parent relies on subsidiary payments. Fiduciary assets are unavailable; undrawn facility capacity and complete maturities are not supplied.

asset liability risk · 2/4 · Marsh is not principal to the underlying insurance contracts, limiting direct underwriting exposure. Corporate debt, lease commitments, errors-and-omissions liabilities and a realized litigation charge remain material exposures. Subsidiary funding constraints add complexity; the catalog does not establish complete contingent-loss coverage or regulatory headroom.

earnings resilience · 2/4 · Nine-month 2026 revenue increased to $21.864 billion, including 5% underlying growth, and attributable earnings remained $3.220 billion. Operating income and attributable earnings nevertheless declined year over year. Litigation charges and commission sensitivity to insurance adjustments temper otherwise substantial demonstrated profitability.

Capital allocation50

Qualitative financial_services assessment: equal-weight average of four current evidence-backed grades (0–4), scaled to 100. Policy financial-services-1; not an industrial ratio score or credit rating.

capital efficiency · 2/4 · Substantial positive consolidated earnings relative to the disclosed accounting equity base support productive capital use qualitatively. Earnings declined and goodwill and intangible assets dominate the equity comparison. No reported ROE, regulatory-capital return or acquisition-level return is supplied; no annualized return is inferred.

distributions and buffers · 2/4 · Nine-month dividends of $1.354 billion were below attributable earnings, but combined dividends and $2.016 billion of repurchases exceeded earnings and operating cash after capital expenditure. Corporate cash declined and debt increased. Actual distributions are demonstrated; ample regulatory or contractual headroom is not.

dilution and cost · 2/4 · Employee-related issuance fell to approximately 2.0 million shares, and nine-month diluted average shares declined to 482 million from 495 million. Share-based compensation rose to $329 million from $305 million, while repurchases consumed substantial cash amid borrowing. Net dilution containment does not establish attractive repurchase value.

investment discipline · 2/4 · Disclosed acquisition and investment spending contributed revenue, and contingent consideration generally uses multi-year EBITDA or revenue targets. Current acquisition cash spending and continuing McGriff integration costs demonstrate commitments. Management reports completed integration, but acquisition returns, realized synergies and purchase-price value creation remain unestablished.

Management63

Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.

capital discipline · 2/4 · Annual operating cash generation improved in 2025, and acquisitions contributed disclosed revenue. In nine-month 2026, cash generation weakened while dividends and repurchases exceeded operating cash after capital expenditure and borrowing increased. Spending outcomes are mixed; revenue contribution alone does not demonstrate acquisition returns.

incentive alignment · 3/4 · Actual multi-year vesting, forfeiture provisions and executive ownership requirements support alignment. A realized 0.88x relative-TSR modifier reduced the disclosed PSU payout to 176% of target, demonstrating operation of the mechanism. Ownership compliance and exceptional compensation effectiveness remain unestablished.

execution · 2/4 · Underlying revenue growth and improved 2025 operating cash generation support execution through indirect operating evidence. Management reports completed McGriff integration, but related costs continued in 2026, cash generation weakened and nine-month operating income declined. Integration completion does not establish realized acquisition returns.

governance · 3/4 · An otherwise independent board, separated CEO and chair roles, shareholder special-meeting rights and an adopted conduct clawback provide strong disclosed safeguards. The realized litigation charge warrants scrutiny but does not establish an adjudicated oversight failure. Exceptional effectiveness of these governance structures remains unproven.

Evidence

Guy Carpenter creates and executes reinsurance and risk management solutions globally through risk assessment analytics, actuarial services and trading relationships with reinsurance markets.

2025 Form 10-K, business: reinsurance analytics and trading relationships · Filed 09/02/2026

•Career: advising on employee engagement, skill assessment, executive remuneration, HR effectiveness and M&A strategy utilizing proprietary data and tools.

2025 Form 10-K, business: Mercer proprietary data and tools · Filed 09/02/2026

Through Marsh's patented electronic platform, MarketConnect, and sophisticated data analysis, ICG provides insurers with individualized preference setting and risk identification capabilities, as well as detailed performance data and metrics.

2024 Form 10-K, business: historical MarketConnect platform disclosure · Filed 10/02/2025

In Risk and Insurance Services, underlying revenue growth in 2025 was driven by higher new business and renewal revenue at Marsh Risk and Guy Carpenter, partially offset by declining insurance and reinsurance premium rates.

2025 Form 10-K, operating results: new business, renewals and premium rates · Filed 09/02/2026

If a key employee were to join an existing competitor or form a competing company, some of our clients could choose to use the services of a competitor instead of our services.

2025 Form 10-K, risk: employee-related client mobility · Filed 09/02/2026

Many of our clients, including financial institutions, corporations, government entities and pension plans, have reduced expenses, including amounts spent on consulting services, and used internal resources instead of consultants during difficult economic periods.

2025 Form 10-K, risk: historical client insourcing · Filed 09/02/2026

•fluctuations in capacity and utilization rates and clients' ability to terminate engagements without penalty;

2025 Form 10-K, risk: consulting termination rights · Filed 09/02/2026

The consulting business faces competition from global, regional and local firms, including independent consulting, broking and outsourcing firms affiliated with accounting, technology and financial services and new entrants utilizing generative AI.

2025 Form 10-K, competition: consulting firms and generative AI entrants · Filed 09/02/2026

For the nine months ended September 30, 2026, consolidated revenue was $21.9 billion, an increase of 7%, or 5% on an underlying basis.

September 2026 Form 10-Q, nine-month consolidated revenue growth · Filed 15/10/2026

MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (In millions, except per share data) 2026 2025 2026 2025 Revenue $ 6,863 $ 6,351 $ 21,864 $ 20,386 Expense: Compensation and benefits 4,078 3,894 12,349 11,639 Other operating expenses 1,570 1,287 4,647 3,743 Operating expenses 5,648 5,181 16,996 15,382 Operating income 1,215 1,170 4,868 5,004 Other net benefit credits 48 52 148 143 Interest income 10 10 29 34 Interest expense (248) (237) (738) (725) Investment income 8 15 9 27 Income before income taxes 1,033 1,010 4,316 4,483 Income tax expense 221 253 1,027 1,083 Net income before non-controlling interests 812 757 3,289 3,400 Less: Net income attributable to non-controlling interests 4 10 69 61 Net income attributable to the Company $ 808 $ 747 $ 3,220 $ 3,339 Net income per share attributable to the Company: – Basic $ 1.70 $ 1.52 $ 6.71 $ 6.79 – Diluted $ 1.69 $ 1.51 $ 6.68 $ 6.75 Average number of shares outstanding: – Basic 476 491 480 492 – Diluted 479 494 482 495 Shares outstanding at September 30, 475 490 475 490

September 2026 Form 10-Q, unaudited consolidated statements of income · Filed 15/10/2026

Commission rates and fees vary in amount and depend on coverage provided, the insurer or reinsurer selected, and the capacity in which the broker acts and negotiates with clients.

2025 Form 10-K, compensation: commission and fee negotiation · Filed 09/02/2026

Insurance exposures subject to variable factors are subject to mid-term and end of term adjustments, as well as policy audits, which may reduce premiums and corresponding commissions.

September 2026 Form 10-Q, revenue economics: premium and commission adjustments · Filed 15/10/2026

Risk & Insurance Services Consulting Corporate/ Eliminations Total Three Months Ended September 30, 2026 Operating income (loss) $ 745 $ 563 $ (93) $ 1,215 Operating margin 17.8 % 21.0 % N/A 17.7 % Add (deduct) impact of noteworthy items: Restructuring (a) 44 10 25 79 Changes in contingent and deferred consideration (b) 11 1 — 12 McGriff integration and retention related costs 33 — 2 35 Greensill litigation (c) 144 — — 144 Legal matter (d) 30 — — 30 Gain on consolidation of entity (e) (126) — — (126) Acquisition and disposition related gains (1) (1) (2) (4) Total noteworthy items 135 10 25 170 Identified intangible amortization expense 122 20 — 142 Operating income adjustments 257 30 25 312 Adjusted operating income (loss) $ 1,002 $ 593 $ (68) $ 1,527 Adjusted operating margin 24.6 % 22.1 % N/A 22.7 % Three Months Ended September 30, 2025 Operating income (loss) $ 750 $ 501 $ (81) $ 1,170 Operating margin 19.2 % 20.3 % N/A 18.4 % Add (deduct) impact of noteworthy items: Restructuring (a) 20 18 8 46 Changes in contingent and deferred consideration (b) 32 2 — 34 McGriff integration and retention related costs 50 — 2 52 Acquisition related costs — 7 — 7 Acquisition and disposition related gains (3) — — (3) Total noteworthy items 99 27 10 136 Identified intangible amortization expense 116 17 — 133 Operating income adjustments 215 44 10 269 Adjusted operating income (loss) $ 965 $ 545 $ (71) $ 1,439 Adjusted operating margin 24.7 % 22.1 % N/A 22.7 % (a)Primarily reflects costs related to the Company's three-year program, Thrive, which focuses on our brand strategy, delivering greater value to clients, accelerating growth and improving efficiency.

Third-quarter 2026 results, comparative operating-margin reconciliation · Filed 15/10/2026

For the three and nine months ended September 30, 2026 and 2025, adjusted operating margin is calculated by dividing the sum of adjusted operating income by consolidated or segment adjusted revenue.

Third-quarter 2026 results, adjusted operating-margin definition · Filed 15/10/2026

The Company's adjusted revenue used in the determination of adjusted operating margin is calculated by excluding the impact of certain noteworthy items from the Company's GAAP revenue.

Third-quarter 2026 results, adjusted revenue definition · Filed 15/10/2026

In the first quarter of 2025, the Company changed its methodology to report adjusted operating income (loss), adjusted income, net of tax and adjusted EPS to exclude the impact of intangible amortization and other net benefit credits.

2026 proxy, change in adjusted earnings methodology · Filed 31/03/2026

Operating Cash Flows The Company provided $5.3 billion of cash from operations in 2025 compared to $4.3 billion in 2024.

2025 Form 10-K, annual operating cash flows · Filed 09/02/2026

Operating cash flows: Net income before non-controlling interests $ 3,289 $ 3,400 Adjustments to reconcile net income to cash provided by operations: Depreciation and amortization 685 682 Non-cash lease expense 223 219 Gain on consolidation of entity (126) (13) Share-based compensation expense 329 305 Net (gain) on investments, disposition of assets and other (52) (26) Changes in assets and liabilities: Accrued compensation and employee benefits (639) (610) Provision for taxes, net of payments and refunds 69 197 Net receivables (872) (388) Other changes to assets and liabilities (131) (196) Contributions to pension and other benefit plans in excess of current year credit (210) (190) Operating lease liabilities (252) (249) Net cash provided by (used for) operations 2,313 3,131 Financing cash flows: Purchase of treasury shares (2,016) (1,002) Net proceeds from issuance of commercial paper 1,623 — Proceeds from issuance of debt 595 — Repayments of debt (1,247) (514) Payment to acquire non-controlling interest (54) — Net issuance of common stock from treasury shares (6) 64 Net distributions of non-controlling interests and deferred/contingent consideration (174) (110) Dividends paid (1,354) (1,255) Change in fiduciary liabilities 869 231 Net cash provided by (used for) financing activities (1,764) (2,586) Investing cash flows: Capital expenditures (215) (186) Purchases of long-term investments and other (34) (23) Sales of long-term investments 3 96 Dispositions

Third-quarter 2026 results, nine-month operating and financing cash-flow rows · Filed 15/10/2026

Consolidated Statements of Cash Flows (Millions) (Unaudited) Nine Months Ended September 30, 2026 2025 Operating cash flows: Net income before non-controlling interests $ 3,289 $ 3,400 Adjustments to reconcile net income to cash provided by operations: Depreciation and amortization 685 682 Non-cash lease expense 223 219 Gain on consolidation of entity (126) (13) Share-based compensation expense 329 305 Net (gain) on investments, disposition of assets and other (52) (26) Changes in assets and liabilities: Accrued compensation and employee benefits (639) (610) Provision for taxes, net of payments and refunds 69 197 Net receivables

Third-quarter 2026 results, cash-flow table units, periods and compensation expense · Filed 15/10/2026

Capital expenditures (215) (186) Purchases of long-term investments and other (34) (23) Sales of long-term investments 3 96 Dispositions 16 15 Acquisitions, net of cash and cash held in a fiduciary capacity acquired (263) (224) Net cash provided by (used for) investing activities (493) (322) Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (101) 615 Increase (Decrease) in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (45) 838 Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period 14,160 13,674 Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period $ 14,115 $ 14,512 Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets Balance at September 30, 2026 2025 (In millions) Cash and cash equivalents $ 1,842 $ 2,511 Cash and cash equivalents held in a fiduciary capacity 12,273 12,001 Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity $ 14,115 $ 14,512 13 Marsh & McLennan Companies, Inc.

Third-quarter 2026 results, investing cash flows and cash reconciliation · Filed 15/10/2026

(Unaudited) September 30, 2026 December 31, 2025 ASSETS Current assets: Cash and cash equivalents $ 1,842 $ 2,687 Cash and cash equivalents held in a fiduciary capacity 12,273 11,473 Net receivables 8,548 7,670 Other current assets 1,444 1,370 Total current assets 24,107 23,200 Goodwill and intangible assets 29,117 29,083 Fixed assets, net 815 829 Pension related assets 2,301 2,140 Right of use assets 1,414 1,460 Deferred tax assets 195 212 Other assets 1,857 1,786 TOTAL ASSETS $ 59,806 $ 58,710 LIABILITIES AND EQUITY Current liabilities: Short-term debt $ 1,644 $ 1,267 Accounts payable and accrued liabilities 3,583 3,652 Accrued compensation and employee benefits 3,329 3,962 Current lease liabilities 324 333 Accrued income taxes 485 373 Dividends payable 471 — Fiduciary liabilities 12,273 11,473 Total current liabilities 22,109 21,060 Long-term debt 18,889 18,320 Pension, post-retirement and post-employment benefits 693 786 Long-term lease liabilities 1,475 1,529 Liabilities for errors and omissions 281 288 Other liabilities 1,449 1,412 Total equity 14,910 15,315 TOTAL LIABILITIES AND EQUITY $ 59,806 $ 58,710

Third-quarter 2026 results, September 30 consolidated balance sheet · Filed 15/10/2026

out of annual earnings. At September 30, 2026, the Company had approximately $1.7 billion of cash and cash equivalents in its foreign operations, which includes $572 million of operating funds required to be maintained for regulatory requirements or as collateral under certain captive insurance arrangements.

September 2026 Form 10-Q, foreign cash and required operating or collateral funds · Filed 15/10/2026

As the Company does not have significant operations of its own, the Company is dependent upon dividends and other payments from its operating subsidiaries to pay principal and interest on its outstanding debt obligations, pay dividends to stockholders, repurchase its shares and pay corporate expenses.

September 2026 Form 10-Q, parent reliance on subsidiary payments · Filed 15/10/2026

Fiduciary assets cannot be used for general corporate purposes, and should not be considered as a source of liquidity for the Company.

September 2026 Form 10-Q, fiduciary assets unavailable for corporate purposes · Filed 15/10/2026

The Company is not a principal to the contracts under which the right to receive premiums or the right to receive reimbursement of insured losses arises.

September 2026 Form 10-Q, insurance-contract principal status · Filed 15/10/2026

Operating income fell 12% to $1.8 billion and included a $425 million charge related to the Greensill litigation.

First-quarter 2026 results, operating income and Greensill litigation charge · Filed 16/04/2026

◾ We deployed approximately $850 million of capital over 20 acquisitions and investments, which contributed $255 million in revenue.

2026 proxy, acquisition and investment spending and revenue contribution · Filed 31/03/2026

Contingent purchase consideration arrangements are generally based primarily on EBITDA or revenue targets over a period of 2 to 4 years.

September 2026 Form 10-Q, contingent acquisition consideration terms · Filed 15/10/2026

These costs included approximately $35 million and $124 million of integration and retention related costs in connection with the acquisition of McGriff Insurance Services for the three and nine months ended September 30, 2026, and $52 million and $166 million, respectively, for the corresponding periods in the prior year.

September 2026 Form 10-Q, McGriff integration and retention costs · Filed 15/10/2026

We completed the integration of MMA’s acquisition of McGriff Insurance Services.

2026 proxy, management report of McGriff integration completion · Filed 31/03/2026

Executive Stock Ownership Guidelines Our senior executives are required to acquire and hold shares or stock units (excluding PSUs) of our common stock with an aggregate value at least equal to a specified multiple of their base salary.

2026 proxy, executive stock ownership requirements · Filed 31/03/2026

All equity-based awards are subject to multi-year vesting requirements or performance periods with complete forfeiture of unvested awards upon a voluntary termination of employment by a senior executive (other than by reason of retirement) or termination of employment for cause.

2026 proxy, multi-year vesting and forfeiture terms · Filed 31/03/2026

However, our three-year TSR was at the 38th percentile versus S&P 500 constituents*, which resulted in a 0.88x relative TSR modifier and a payout of 176% of target.

2026 proxy, realized relative-TSR modifier and PSU payout · Filed 31/03/2026

The PSU awards granted in February 2023 vested on February 28, 2026, and PSU awards granted in February 2024 and February 2025 will vest on February 28, 2027 and February 28, 2028, respectively, and will be paid in a number of shares of the Company’s common stock determined based on actual performance over the applicable three-year performance period.

2026 proxy, actual 2023 PSU vesting and subsequent award schedules · Filed 31/03/2026

All of the Company’s directors are independent, with the exception of our CEO, who is the only member of management serving on the Board.

2026 proxy, board independence · Filed 31/03/2026

• Independent Chair. The Company maintains separate roles of chief executive officer and Board chair as a matter of policy.

2026 proxy, separation of CEO and board chair · Filed 31/03/2026

ü Our bylaws allow holders of at least 20% of the voting power of the Company’s outstanding common stock to call a special meeting.

2026 proxy, shareholder special-meeting rights · Filed 31/03/2026

The Compensation Committee adopted an additional clawback policy for senior executives that provides recoupment of certain incentive compensation in the event a senior executive engages in specified detrimental conduct.

2026 proxy, adopted detrimental-conduct clawback · Filed 31/03/2026

The Company issued approximately 2.0 million and 3.2 million shares related to stock compensation and employee stock purchase plans for the nine months ended September 30, 2026 and 2025, respectively.

September 2026 Form 10-Q, employee-related share issuance · Filed 15/10/2026

Publication history

Publication history
VersionUpdatedCompetitive advantage
1129/10/2026narrow
1028/10/2026narrow
924/10/2026narrow
823/10/2026narrow
722/10/2026narrow
619/10/2026narrow
519/10/2026narrow
419/10/2026narrow
318/10/2026narrow
218/10/2026narrow

Sources

Research methodology and limitations · What is an economic moat?